Clinical Guidelines & Pathways


Treatment Pathway for Moderate to Severe Atopic Dermatitis in Adults (after inadequate response to topical treatments and conventional systemic therapies)


Approved by BLMK Area Prescribing Committee (APC): May 2023

View Document

Guideline Categories: Dermatology

Guideline Tags: atopic, dermatitis, JAK inhibitors

Please use the search box to search the whole site if you can't find what you're looking for:

To top
Welcome to the BLMK Medicines Optimisation website.
This site is currently being updated.

If you have any feedback or find any issues, please email the team:
BLMKICB.MedsOpt@nhs.net